top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
COVID-19
Contact
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Biosimilars
Radioligand therapy
Chikungunya News
NICE recommendations
G-BA Assessment Outcomes
HAS Assessment Outcomes
Neurology
Immunology
Search
Log in / Sign up
ipharmaservices
Oct 9, 2024
Merck's Keytruda Shows Improvement in Event-Free Survival (EFS) in Perioperative Treatment for Patients with Resected Locally Advanced Head and Neck Squamous Cell Carcinoma
ipharmaservices
Aug 9, 2024
Merck's Keytruda plus vibostolimab fails to improve over Tecentriq in ES-SCLC patients | iPharmaCenter
ipharmaservices
Apr 13, 2024
Colorectal cancer | News | Media | Updates
ipharmaservices
Jan 16, 2024
Gastric cancer news | 2024 | iPharmaCenter
ipharmaservices
Nov 2, 2023
Renal cell carcinoma | Kidney cancer | News | Blogs | iPharmaCenter
ipharmaservices
Sep 22, 2023
Esophageal squamous cell carcinoma | News | Updates | iPharmaCenter
ipharmaservices
Sep 6, 2023
NSCLC Drug Development Updates | Lung cancer news
ipharmaservices
May 4, 2023
Non-Hodgkin lymphoma news | Breyanzi efficacy in FL and MCL
ipharmaservices
Apr 17, 2023
Mantle Cell Lymphoma News | Blogs | iPharmaCenter
ipharmaservices
Mar 27, 2023
Breast Cancer News | Verzenio | Kisqali | Ibrance | Enhertu | iPharmaCenter
ipharmaservices
Mar 19, 2023
Prostate Cancer | 2023 | News | Blogs | iPharmaCenter
ipharmaservices
Nov 29, 2022
Gastric Cancer | News | Blogs | iPharmaCenter
ipharmaservices
Aug 18, 2022
Myelofibrosis | News | Blogs | Updates | GSK | iPharmaCenter
ipharmaservices
Jan 17, 2022
Breast Cancer News | Blogs | Keytruda, Trodelvy was approved for TNBC | iPhamaCenter
bottom of page